SLC16A14 and ovarian carcinoma: However, higher expression of SLC16A14 was associated with longer progression-free survival of patients with ovarian cancer [77, 78], and, conversely, was implicated in resistance to chemotherapy of ovarian cancer cell lines [79, 80].